Brian Sun is SVP & General Counsel of Turning Point Therapeutics, Inc.. Currently has a direct ownership of 0 shares of TPTX, which is worth approximately $0. The most recent transaction as insider was on Aug 17, 2022, when has been sold 45,000 shares (Common Stock) at a price of $76.0 per share, resulting in proceeds of $3,420,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Brian Sun Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 17 2022
SELL
Sale (or disposition) back to the issuer
$3,420,000 $76.0 p/Share
45,000 Reduced 100.0%
0 Common Stock
Apr 11 2022
BUY
Grant, award, or other acquisition
-
45,000 Added 50.0%
45,000 Common Stock
BS

Brian Sun

SVP & General Counsel
San Diego, CA

Track Institutional and Insider Activities on TPTX

Follow Turning Point Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TPTX shares.

Notify only if

Insider Trading

Get notified when an Turning Point Therapeutics, Inc. insider buys or sells TPTX shares.

Notify only if

News

Receive news related to Turning Point Therapeutics, Inc.

Track Activities on TPTX